X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.fiercebiotech.com/biotech/century-elevation-are-latest-follow-layoff-pipeline-cull-route-nabriva-winds-down
https://www.globenewswire.com//news-release/2023/01/06/2584338/37424/en/Nabriva-Therapeutics-Provides-Corporate-Update.html
https://www.globenewswire.com//news-release/2022/11/28/2563012/37424/en/Nabriva-Therapeutics-Announces-Positive-Topline-Results-from-Phase-1-Trial-of-XENLETA-lefamulin-in-Adult-Patients-with-Cystic-Fibrosis.html
https://www.fiercebiotech.com/biotech/nabriva-halts-rd-lays-40-staff-commercial-focused-pivot-survival
https://www.globenewswire.com/news-release/2022/11/10/2553732/37424/en/Nabriva-Therapeutics-Pivoting-Strategic-Focus-Reports-Third-Quarter-Financial-Results-and-Provides-Corporate-Update.html
https://www.globenewswire.com/news-release/2022/11/07/2549506/37424/en/Nabriva-Therapeutics-to-Report-Third-Quarter-2022-Financial-Results-and-Recent-Corporate-Highlights-on-November-10-2022.html
https://www.globenewswire.com/news-release/2022/09/15/2516745/37424/en/Nabriva-Therapeutics-Announces-Date-of-1-for-25-Reverse-Stock-Split.html
https://www.globenewswire.com/news-release/2022/09/06/2510222/37424/en/Nabriva-Therapeutics-to-Participate-in-the-H-C-Wainwright-24th-Annual-Global-Investment-Conference.html
https://www.globenewswire.com/news-release/2022/08/11/2496605/37424/en/Nabriva-Therapeutics-Completes-Patient-Enrollment-in-Phase-1-Trial-of-XENLETA-lefamulin-in-Adult-Patients-with-Cystic-Fibrosis.html
https://www.globenewswire.com/news-release/2022/08/03/2491741/37424/en/Nabriva-Therapeutics-Reports-Second-Quarter-2022-Financial-Results-and-Provides-a-Corporate-Update.html
Market Place
Share 
